Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Veteran's psoriasis requires constant or near-constant systemic therapy over the past 12 months, warranting a 60 percent disability rating from June 11, 2024.

The Board dismissed the appeals for service connection for sleep apnea, a migraine headache disorder, and bilateral tinea pedis as they were not proper appeals under the Appeals Management Act appellate system.

The appeal for service connection and initial rating for various conditions was dismissed due to the submission of a duplicate Notice of Disagreement.

The Board granted service connection for generalized anxiety disorder but denied service connection for acne, hypertension (claimed as high blood pressure), and bacterial vaginitis.

The Board granted a 100 percent disability rating for posttraumatic stress disorder (PTSD) and a 50 percent rating for migraine headaches, while denying other claims.

The Board granted a 2020 clothing allowance for the topical medications condylox and Drysol, but denied it for selenium sulfide.

The Board denied service connection for various conditions, including hearing impairment, tinnitus, hypertension, Parkinson's disease, hypothyroidism, melanoma, acne, COPD, and left and right foot disabilities.

The Veteran's service-connected disabilities result in the need for regular aid and attendance, warranting special monthly compensation.

The Board remands the claims for increased ratings for pseudofolliculitis barbae and upper lip scar disabilities to obtain complete medical examinations and adequate opinions for rating purposes.

The Board denied service connection for posttraumatic stress disorder (PTSD), hearing loss, pseudofolliculitis barbae, and total left knee arthroscopy due to the appellant's discharge under other than honorable conditions.

The Board dismissed the appeals for service connection for obstructive sleep apnea, left knee pain, patellofemoral syndrome, and recurrent dermatitis/eczema of the posterior neck and bilateral hands due to untimely Notice of Disagreement (NOD) filings.

The Board granted service connection for pseudofolliculitis barbae and headaches, but remanded the claims for left foot pes planus, plantar fasciitis, right ankle disability, and hypertension.

The Board granted service connection for alcohol use disorder as secondary to the Veteran's PTSD and denied a rating greater than 60 percent for eczema and herpes simplex. The effective date of October 4, 2023 was granted for the grant of service connection for PTSD.

The Board denied an initial compensable rating for pseudofolliculitis barbae with residual scarring, finding that the evidence did not support a higher rating.

The Board denied service connection for hypertension and residuals of a stroke, finding no evidence linking these conditions to the Veteran's active service. The claims for acne, erectile dysfunction, and sinusitis were remanded for further development.

The Board denied a higher disability rating for hypertension and a compensable rating for eczema prior to May 19, 2023. The claim for TDIU was remanded.

The Veteran withdrew his appeal seeking a higher rating for leishmaniasis and id reaction dermatitis, bilateral lower extremities.

The Board granted service connection for a skin condition, diagnosed as seborrheic dermatitis, due to exposure to toxins in the Persian Gulf War based on medical evidence showing that seborrheic dermatitis was twice as common as expected in Gulf veterans.

The Board denied the Veteran's claim for an initial compensable rating for myeloma skin cancer, posterior trunk scar and remanded the issue of entitlement to an initial compensable rating for tinea versicolor disability.

The Board granted a 10 percent rating for impetigo and denied all other claims for increased ratings.